silybin has been researched along with Memory Disorders in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, J; Chen, YX; Dong, Y; Gao, H; Gu, Z; Jin, G; Li, X; Na, X; Su, Y; Wang, S; Wei, P; Wei, X; Yin, H; Yuan, J | 1 |
| Cui, L; Hattori, S; Hayashi, T; Ikejima, T; Liu, B; Liu, P; Liu, W; Mizuno, K; Onodera, S; Ushiki-Kaku, Y | 1 |
| Bai, D; Gan, S; Jin, G; Liu, X; Ren, L; Sun, Y; Yang, Z; Yin, S; Zhu, Q; Zou, D | 1 |
| Cui, L; Hattori, S; Hayashi, T; Ikejima, T; Liu, B; Liu, L; Liu, W; Song, X; Tashiro, SI; Ushiki-Kaku, Y; Xia, M; Yao, G; Zhou, B | 1 |
| Hayashi, T; Ikejima, T; Liu, B; Liu, P; Liu, W; Liu, X; Onodera, S; Song, X | 1 |
| Garabadu, D; Joshi, R; Krishnamurthy, S; Teja, GR | 1 |
| Hayashi, T; Ikejima, T; Lei, D; Onodera, S; Song, X; Tashiro, S; Wang, Y; Xia, M; Yao, G; Zhang, P; Zhou, B | 1 |
| Bai, D; Jin, G; Li, X; Sun, Y; Yang, Z; Yin, S; Zhang, Z; Zhu, Q; Zou, D | 1 |
| Cui, L; Hattori, S; Hayashi, T; Ikejima, T; Lei, D; Onodera, S; Song, X; Tashiro, SI; Ushiki-Kaku, Y; Xia, M; Yao, G; Zhang, P; Zhou, B | 1 |
| Hiramatsu, M; Ikejima, T; Lu, LL; Lu, P; Mamiya, T; Mouri, A; Nabeshima, T; Nagai, T; Zou, L | 1 |
| Hiramatsu, M; Ikejima, T; Lu, LL; Lu, P; Mamiya, T; Mouri, A; Nabeshima, T; Nagai, T; Niwa, M; Zou, LB | 1 |
| Ikejima, T; Kim, HC; Lu, L; Lu, P; Mamiya, T; Mouri, A; Nabeshima, T; Nagai, T; Niwa, M; Yamada, K; Zou, LB | 1 |
| Kamat, PK; Nath, C; Shukla, R; Tota, S | 1 |
13 other study(ies) available for silybin and Memory Disorders
| Article | Year |
|---|---|
Silibinin Ameliorates Formaldehyde-Induced Cognitive Impairment by Inhibiting Oxidative Stress.
Topics: Alzheimer Disease; Animals; Antioxidants; Cognitive Dysfunction; Formaldehyde; Glycogen Synthase Kinase 3 beta; Hippocampus; Memory Disorders; Mice; NF-E2-Related Factor 2; Oxidative Stress; Silybin; Silybum marianum; Silymarin | 2022 |
Silibinin ameliorates STZ-induced impairment of memory and learning by up- regulating insulin signaling pathway and attenuating apoptosis.
Topics: Animals; Apoptosis; Cerebral Cortex; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Hippocampus; Insulin; Insulin-Like Growth Factor I; Male; Memory Disorders; Nerve Degeneration; Neuroprotective Agents; Phosphorylation; Rats; Signal Transduction; Silybin; Streptozocin; tau Proteins | 2020 |
Antioxidative and Anti-Apoptotic Roles of Silibinin in Reversing Learning and Memory Deficits in APP/PS1 Mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Antioxidants; Apoptosis; Disease Models, Animal; Hippocampus; Maze Learning; Memory Disorders; Mice, Transgenic; Oxidative Stress; Silybin; Silymarin | 2017 |
Estrogen Receptors Are Involved in the Neuroprotective Effect of Silibinin in Aβ
Topics: Amyloid beta-Peptides; Animals; Antioxidants; Dose-Response Relationship, Drug; Male; Maze Learning; Memory Disorders; Neuroprotective Agents; Peptide Fragments; Rats; Receptors, Estrogen; Silybin; Silymarin | 2018 |
Silibinin Alleviates the Learning and Memory Defects in Overtrained Rats Accompanying Reduced Neuronal Apoptosis and Senescence.
Topics: Aging; Animals; Apoptosis; Catalase; Hippocampus; Male; Malondialdehyde; Maze Learning; Memory Disorders; Neuroprotective Agents; Oxidative Stress; Physical Conditioning, Animal; Rats, Sprague-Dawley; Silybin; Superoxide Dismutase | 2019 |
Silibinin ameliorates LPS-induced memory deficits in experimental animals.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Antioxidants; Dose-Response Relationship, Drug; Hippocampus; Lipopolysaccharides; Male; Maze Learning; Memory; Memory Disorders; Rats; Rats, Wistar; Silybin; Silymarin | 2014 |
Protective Effect of Silibinin on Learning and Memory Impairment in LPS-Treated Rats via ROS-BDNF-TrkB Pathway.
Topics: Animals; Antioxidants; Brain-Derived Neurotrophic Factor; Dose-Response Relationship, Drug; Lipopolysaccharides; Male; Memory Disorders; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, trkB; Signal Transduction; Silybin; Silymarin; Treatment Outcome | 2016 |
Silibinin rescues learning and memory deficits by attenuating microglia activation and preventing neuroinflammatory reactions in SAMP8 mice.
Topics: Adaptor Proteins, Signal Transducing; Animals; Cerebral Cortex; Cyclooxygenase 2; Encephalitis; Extracellular Signal-Regulated MAP Kinases; Hippocampus; Interleukin-4; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Learning; Male; Maze Learning; Memory; Memory Disorders; Mice; Microglia; Neuroprotective Agents; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Silybin; Silymarin; Spatial Memory | 2016 |
Silibinin ameliorates Aβ
Topics: Amyloid beta-Peptides; Animals; Antioxidants; Autophagy; Dose-Response Relationship, Drug; Inflammation; Male; Memory Disorders; Oxidative Stress; Peptide Fragments; Random Allocation; Rats; Rats, Sprague-Dawley; Silybin; Silymarin | 2017 |
Silibinin prevents amyloid beta peptide-induced memory impairment and oxidative stress in mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Exploratory Behavior; Glutathione; Hippocampus; Lipid Peroxidation; Male; Malondialdehyde; Maze Learning; Memory Disorders; Mice; Mice, Inbred ICR; Motor Activity; Neuroprotective Agents; Oxidative Stress; Peptide Fragments; Recognition, Psychology; Silybin; Silymarin | 2009 |
Silibinin attenuates amyloid beta(25-35) peptide-induced memory impairments: implication of inducible nitric-oxide synthase and tumor necrosis factor-alpha in mice.
Topics: Amyloid beta-Peptides; Animals; Antioxidants; Drug Synergism; Inflammation Mediators; Male; Memory Disorders; Mice; Mice, Inbred ICR; Nitric Oxide Synthase Type II; Peptide Fragments; RNA, Messenger; Silybin; Silymarin; Tumor Necrosis Factor-alpha; Tyrosine; Up-Regulation | 2009 |
Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment.
Topics: Animals; Brain; Cognition; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Hippocampus; Male; Memory Disorders; Methamphetamine; Mice; Mice, Inbred ICR; Nootropic Agents; Prefrontal Cortex; Recognition, Psychology; Serotonin; Silybin; Silymarin | 2010 |
Improvement of brain energy metabolism and cholinergic functions contributes to the beneficial effects of silibinin against streptozotocin induced memory impairment.
Topics: Acetylcholinesterase; Adenosine Triphosphate; alpha7 Nicotinic Acetylcholine Receptor; Animals; Antioxidants; Brain; Calcium; Disease Models, Animal; Drug Evaluation, Preclinical; Energy Metabolism; Glutathione; Male; Malondialdehyde; Maze Learning; Memory Disorders; Mice; Motor Activity; Oxidative Stress; Reactive Nitrogen Species; Reactive Oxygen Species; Receptors, Nicotinic; Silybin; Silymarin; Streptozocin; Synaptosomes | 2011 |